Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 16 of 16 for “"left ventricular ejection fraction (LVEF)"”.
-
Early Identification of Chemotherapy Induced Cardiotoxicity Using Structural and Functional Cardiovascular MRI
… induce nonfocal cardiac injury to the left ventricular (LV) myocardium. This damage, chemotherapy induced cardiotoxicity, is difficult to detect noninvasively prior to the advancement of injury to an irreversible state with decrements in left ventricular ejection fraction (LVEF). As …
-
Maternal and fetal outcome of subsequent pregnancy in patients with documented peripartum cardiomyopathy
… within 6-months follow-up. Overall relapse rate, left ventricular ejection fraction (LVEF) <50% or death after at least 6 months follow-up, was 30%, with 16% (3/18) mortality. Persistently reduced LVEF (<50%) before entering SSP was present in 44% of patients, while full recovery (LVEF≥ 50%) was …
-
Echocardiographic Evaluation of Left Ventricular Recovery After Refractory Out-of-Hospital Cardiac Arrest
… design to evaluate patients with refractory ventricular tachycardia/ventricular fibrillation out-of-hospital cardiac arrest who were treated with the Minnesota Resuscitation Consortium protocol. Left ventricular ejection fraction (LVEF), end-diastolic diameter (LVEDD), end-systolic diameter …
-
Extended electrocardiographic monitoring in patients on chronic haemodialysis and after renal transplantation
… the median age was 38 years (IQR 27.5 – 45) and left ventricular ejection fraction (LVEF) 62% (48 – 73). Clinically significant arrhythmias included atrioventricular (AV) block (n=24), atrial fibrillation (n=12) and non-sustained ventricular tachycardia (n=2). Most (57.4%) arrhythmic events …
-
EFFECTS OF DAPAGLIFLOZIN ON EXERCISE CAPACITY, RESPIRATORY FUNCTION, BIOMARKERS, SLEEP APNEA, AND LEFT VENTRICULAR REMODELING IN PATIENTS WITH HEART FAILURE: A PROSPECTIVE, SINGLE CENTER, NON RANDOMIZED STUDY
… in the management of heart failure with reduced ejection fraction (HFrEF). Its clinical efficacy is well-established, primarily attributed to its effects on diuresis and hemodynamic unloading. However, despite its widespread use and therapeutic success, the precise mechanisms through which …
-
Dysfunctional but viable myocardium - ischemic heart disease assessed by magnetic resonance imaging and single photon emission computed tomography
… method for quantitative polar representation of left ventricular myocardial function, perfusion and viability using single photon emission computed tomography (SPECT) and cardiac magnetic resonance (CMR). Polar representation of these parameters was feasible, and the quantitative method agreed …
-
Device Therapy In Heart Failure Population In New Zealand
… (CRT-D) in patients with impaired left ventricular ejection fraction (LVEF). Chapter 4 describes a study that evaluates the role of a simple risk score to identify HF patients who should have CRT-D versus those who should be treated with a CRT-P even when fulfilling ICD implantation …
-
The role of self-compassion in adjustment following myocardial infarction
… function post MI was assessed using a measure of left ventricular ejection fraction (LVEF). Attendance at cardiac rehabilitation (decision to opt in or out) was used as an index of behavioural adjustment.<br/><br/>Results: As predicted, higher levels of self-compassion were associated with lower …
-
Dipeptidyl Peptidase-4 in Cariometabolic Disease
… pathways in Dpp4hep-/- were reduced in ventricular tissue. Despite these molecular changes in the heart, there were no functional changes in systolic and diastolic parameters. Lastly, Dpp4-/-, Dpp4hep-/- and Dpp4EC-/- mice were treated with sitagliptin, metformin or a combination of …
-
Gender Aspects on Heart Failure
… have similar long-term survival, irrespective of LVEF, medication and all other relevant baseline variables. Paper IV: We prospectively assessed gender differences in factors related to Brain-natriuretic peptide (BNP), left ventricular ejection fraction (LVEF) and mass (LVM), and peak oxygen …
-
The nature of cachexia in patients with heart failure and stable coronary artery disease
… 1) HF-cachexia - patients with HF, reduced left ventricular systolic function and cachexia, n=10; 2) HF-no cachexia - those with HF, reduced systolic function but no cachexia, n=20; and 3) CAD - those with CAD, no symptoms of HF and preserved systolic function, n=10. The other subject groups …
-
Computational modeling of the tissue mechanics in rheumatic heart disease patients
… for diastolic abnormalities linked to ventricular hypertrophy and inflammation. This study aims to develop accurate, subject-specific computational models of the human bi-ventricle using high-resolution cardiovascular magnetic resonance (CMR) images from rheumatic heart disease patients …
-
The genetics of anthracycline-induced cardiotoxicity in cancer patients
… which may influence this adverse drug reaction. Left ventricular ejection fraction (LVEF) acts as a surrogate measure of cardiac function in the public health-care setting. OBJECTIVES: To provide insight into the clinical management of breast cancer patients on anthracycline-based treatment with …
-
Physiology-inspired deep learning for improved heart failure management
… a RHC at MGH, and used CHAIS to infer if their left atrial pressures would be elevated at the time of their RHC. CHAIS achieves an AUROC of 0.80 for detecting elevated left atrial pressures on the internal test dataset and 0.76 on the external validation set. On patients who wore a wearable ECG …
-
THE ROLE OF EXTRACELLULAR VESICLES IN HEART DISEASES
… with HF with reduced (HFrEF) and preserved ejection fractions (HFpEF), focusing on their potential utility in phenotypic refinement, and comparison with healthy controls. By analyzing these two pathologically distinct cardiac conditions, this project also seeks to determine whether …
-
Beta-blocker therapy in the era of primary percutaneous intervention for ST elevation myocardial infarction
… (STEMI) was believed as therapeutic effects of left ventricular (LV) dysfunction. With present therapeutic advance, numbers of STEMI patients with LV dysfunction have been decreased. We studied the long term clinical outcomes of betablocker therapy after successful primary percutaneous coronary …